Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
Cooley represented a syndicate of investors in the approximately $2.25 billion management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform.